Last quarter (Q ), CBD Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, CBD Life Sciences's net income was $-21.72K. See CBD Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 14	Dec 13	Dec 12	Dec 11
Total Revenue	$ 122.79K	$ 122.79K	$ 155.55K	$ 0.00	$ 0.00
Cost of Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 122.79K	$ 122.79K	$ 155.55K	$ 0.00	$ 0.00
Operating Expense	$ 218.46K	$ 883.80K	$ 499.04K	$ 155.72K	$ 52.74K
Operating Income	$ -95.67K	$ -761.01K	$ -343.49K	$ -155.72K	$ -52.74K
Net Non Operating Interest Income Expense	$ -3.58K	$ -15.27K	$ -23.50K	-	-
Other Income Expense	-	$ -3.86K	$ -141.00	$ -610.00	-
Pretax Income	$ -103.11K	$ -780.14K	$ -367.13K	$ -156.33K	$ -52.74K
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -103.11K	$ -780.14K	$ -367.13K	$ -156.33K	$ -52.74K
Basic EPS	$ 437.50	$ -42.50	$ -2.50K	$ -2.50K	$ -1.25K
Diluted EPS	$ 437.50	$ -42.50	$ -2.50K	$ -2.50K	$ -1.25K
Basic Average Shares	$ 12.58K	$ 1.82K	$ 160.00	$ 65.00	$ 59.00
Diluted Average Shares	$ 12.58K	$ 1.82K	$ 160.00	$ 65.00	$ 59.00
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	$ 24.18K	$ 88.33K	$ 50.22K	$ 10.50K	$ 6.00K
Total Expenses	$ 218.46K	$ 883.80K	$ 499.04K	$ 155.72K	$ 52.74K
Net Income From Continuing And Discontinued Operation	$ -103.11K	$ -780.14K	$ -367.13K	$ -156.33K	$ -52.74K
Normalized Income	$ -103.11K	$ -776.28K	$ -366.99K	$ -155.72K	$ -52.74K
Interest Expense	$ 3.58K	$ 15.27K	$ 23.50K	-	-
EBIT	$ -99.53K	$ -764.87K	$ -343.63K	$ -155.72K	$ -52.74K
EBITDA	$ -83.57K	$ -741.56K	$ -304.97K	$ -59.75K	$ -52.74K

Currency in USD

CBD Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing